This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Yuji Onizawa: Innovator in Pharmaceutical Chemistry
Introduction
Yuji Onizawa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development efforts.
Latest Patents
Onizawa holds a patent for a compound known as Pyrrolidin-3-ylacetic acid derivative. This compound, represented by a specific formula, exhibits an inhibitory effect in the fractalkine-CX3CR1 pathway. The compound's structure includes various alkyl and halogen substituents, showcasing its potential in pharmaceutical applications.
Career Highlights
Yuji Onizawa is associated with Eisai R&D Management Co., Ltd., where he has been instrumental in advancing research initiatives. His work has led to the development of novel compounds that may have therapeutic benefits.
Collaborations
Throughout his career, Onizawa has collaborated with esteemed colleagues such as Ichiro Yoshida and Tadashi Okabe. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Yuji Onizawa's contributions to pharmaceutical chemistry and his innovative patent highlight his role as a key inventor in the industry. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile